European drug agency approves cannabis-based medicine for severe forms of epilepsy

Pages: l5708 - l5708
Published: Sep 24, 2019
Abstract
The European Medicines Agency (EMA) has approved the first cannabis based medicine to treat two rare and severe forms of childhood onset epilepsy, although hurdles remain before the drug becomes available on the NHS. In August the National Institute for Health and Care Excellence (NICE) published draft guidance saying that on the current evidence it could not recommend cannabidiol as an effective use of NHS resources.1 However, it said it was...
Paper Details
Title
European drug agency approves cannabis-based medicine for severe forms of epilepsy
Published Date
Sep 24, 2019
Journal
Pages
l5708 - l5708
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.